World's Best Scientists 2026 revealed!

D-Index & Metrics

Social Sciences and Humanities

D-Index
49
Citations
10727
World Ranking
2926
National Ranking
209

Ian Kerridge publication distribution in Social Sciences and Humanities in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Social Sciences and Humanities in 2026. The highlighted bar marks where Ian Kerridge sits on this spectrum.

44–53 publications: 28 scientists 54–63 publications: 61 scientists 64–73 publications: 161 scientists 74–83 publications: 225 scientists 84–93 publications: 301 scientists 94–103 publications: 390 scientists 104–113 publications: 406 scientists 114–123 publications: 474 scientists 124–133 publications: 453 scientists 134–143 publications: 434 scientists 144–153 publications: 407 scientists 154–163 publications: 411 scientists 164–173 publications: 391 scientists 174–183 publications: 313 scientists 184–193 publications: 319 scientists 194–203 publications: 304 scientists 204–213 publications: 285 scientists 214–223 publications: 246 scientists 224–233 publications: 213 scientists 234–243 publications: 170 scientists 244–253 publications: 167 scientists 254–263 publications: 162 scientists 264–273 publications: 138 scientists 274–283 publications: 138 scientists 284–293 publications: 113 scientists 294–303 publications: 106 scientists 304–313 publications: 95 scientists 314–323 publications: 101 scientists 324–333 publications: 81 scientists 334–343 publications: 69 scientists 344–353 publications: 56 scientists 354–363 publications: 36 scientists 364–373 publications: 42 scientists 374–383 publications: 41 scientists 384–393 publications: 44 scientists 394–403 publications: 27 scientists 404–413 publications: 30 scientists 414–423 publications: 20 scientists 424–433 publications: 29 scientists 434–443 publications: 29 scientists 444–453 publications: 25 scientists 454–463 publications: 19 scientists 464–473 publications: 21 scientists 474–483 publications: 11 scientists 484–493 publications: 17 scientists 494–503 publications: 7 scientists 504–513 publications: 6 scientists 514–523 publications: 12 scientists 524–533 publications: 10 scientists 534–543 publications: 7 scientists 544–553 publications: 6 scientists 554–563 publications: 12 scientists 564–569 publications: 8 scientists 570+ publications: 100 scientists
44 publications 570+

This scientist: 519 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 570 publications or more.

Ian Kerridge D-index placement in Social Sciences and Humanities in 2026

The chart shows the D-index (discipline H-index) distribution of Social Sciences and Humanities scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Kerridge sits on this spectrum.

30 D-Index: 177 scientists 31 D-Index: 210 scientists 32 D-Index: 222 scientists 33 D-Index: 188 scientists 34 D-Index: 181 scientists 35 D-Index: 243 scientists 36 D-Index: 261 scientists 37 D-Index: 272 scientists 38 D-Index: 278 scientists 39 D-Index: 300 scientists 40 D-Index: 297 scientists 41 D-Index: 308 scientists 42 D-Index: 313 scientists 43 D-Index: 300 scientists 44 D-Index: 269 scientists 45 D-Index: 260 scientists 46 D-Index: 228 scientists 47 D-Index: 251 scientists 48 D-Index: 203 scientists 49 D-Index: 186 scientists 50 D-Index: 187 scientists 51 D-Index: 166 scientists 52 D-Index: 138 scientists 53 D-Index: 141 scientists 54 D-Index: 131 scientists 55 D-Index: 137 scientists 56 D-Index: 109 scientists 57 D-Index: 129 scientists 58 D-Index: 95 scientists 59 D-Index: 105 scientists 60 D-Index: 106 scientists 61 D-Index: 86 scientists 62 D-Index: 94 scientists 63 D-Index: 77 scientists 64 D-Index: 79 scientists 65 D-Index: 59 scientists 66 D-Index: 68 scientists 67 D-Index: 51 scientists 68 D-Index: 49 scientists 69 D-Index: 40 scientists 70 D-Index: 43 scientists 71 D-Index: 40 scientists 72 D-Index: 50 scientists 73 D-Index: 46 scientists 74 D-Index: 43 scientists 75 D-Index: 45 scientists 76 D-Index: 45 scientists 77 D-Index: 30 scientists 78 D-Index: 25 scientists 79 D-Index: 31 scientists 80 D-Index: 29 scientists 81 D-Index: 18 scientists 82 D-Index: 21 scientists 83 D-Index: 26 scientists 84 D-Index: 15 scientists 85 D-Index: 15 scientists 86 D-Index: 19 scientists 87 D-Index: 19 scientists 88 D-Index: 12 scientists 89 D-Index: 7 scientists 90 D-Index: 19 scientists 91 D-Index: 20 scientists 92 D-Index: 13 scientists 93 D-Index: 9 scientists 94 D-Index: 13 scientists 95 D-Index: 8 scientists 96 D-Index: 7 scientists 97 D-Index: 6 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100+ D-Index: 97 scientists
30 D-Index 100+

This scientist: 49 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 100 D-Index or more.

Overview

Ian Kerridge is affiliated with the University of Sydney in Australia and has contributed extensively to the field of Medicine, with a particular focus on Public Health, Environmental and Occupational Health, Hematology, General Health Professions, Oncology, and Physiology. Their research covers a broad range of topics within medical science and ethics, emphasizing biomedical ethics, regulation, and clinical practice.

Kerridge's recent publication record includes influential papers across bioethics and hematology. Notable works include "An Ethics Framework for Making Resource Allocation Decisions Within Clinical Care: Responding to COVID-19" (2020, Journal of Bioethical Inquiry), "Public trust and global biobank networks" (2020, BMC Medical Ethics), and "Science at Warp Speed: Medical Research, Publication, and Translation During the COVID-19 Pandemic" (2020, Journal of Bioethical Inquiry). They also contributed to hematology-focused studies such as "COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity" (2021, British Journal of Haematology) and "Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion" (2022, Blood).

Frequent co-authors in Kerridge's research include Wendy Lipworth, Cameron Stewart, Matthew Greenwood, Andrew Spencer, and Paul A. Komesaroff. The collaboration with these researchers reflects a multidisciplinary approach bridging clinical, ethical, and biomedical perspectives.

Their publication venues commonly include Internal Medicine Journal, Journal of Bioethical Inquiry, Blood, British Journal of Haematology, and Transplantation and Cellular Therapy. These journals align with Kerridge's expertise in clinical medicine and medical ethics.

  • Biomedical Ethics and Regulation
  • Ethics in medical practice
  • Multiple Myeloma Research and Treatments
  • Ethics in Clinical Research
  • Hematopoietic Stem Cell Transplantation
  • Palliative Care and End-of-Life Issues
  • Chronic Lymphocytic Leukemia Research

  • Ian Kerridge (2020) An Ethics Framework for Making Resource Allocation Decisions Within Clinical Care: Responding to COVID-19, Journal of Bioethical Inquiry
  • Ian Kerridge (2020) Public trust and global biobank networks, BMC Medical Ethics
  • Ian Kerridge (2020) Science at Warp Speed: Medical Research, Publication, and Translation During the COVID-19 Pandemic, Journal of Bioethical Inquiry
  • Ian Kerridge (2021) COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity, British Journal of Haematology
  • Ian Kerridge (2022) Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion, Blood

  • Wendy Lipworth
  • Cameron Stewart
  • Matthew Greenwood
  • Andrew Spencer
  • Paul A. Komesaroff

  • Internal Medicine Journal
  • Journal of Bioethical Inquiry
  • Blood
  • British Journal of Haematology
  • Transplantation and Cellular Therapy

Best Publications

  • Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    Michel Attal;Paul G. Richardson;S. Vincent Rajkumar;Jesus San-Miguel

  • Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers

    Josephine M. Clayton;Karen M. Hancock;Phyllis N. Butow;Martin H.N. Tattersall

  • Ethics and Law for the Health Professions.

    I H Kerridge;Michael Peter Lowe;J McPhee

  • Advance care planning for cancer patients: a systematic review of perceptions and experiences of patients, families, and healthcare providers.

    Stephanie Johnson;Phyllis Butow;Ian Kerridge;Martin Tattersall

  • Ethics and evidence based medicine

    Ian Kerridge;Ian Kerridge;Michael Lowe;David Henry

  • Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.

    B George;N Pati;N Gilroy;M Ratnamohan

  • Interprofessionalism and ethics: consensus or clash of cultures?

    Rob Irvine;Ian Kerridge;John McPhee;Sonia Freeman

  • Implementing a One Health approach to emerging infectious disease: reflections on the socio-political, ethical and legal dimensions

    Christopher J Degeling;Christopher J Degeling;Jane Johnson;Ian Kerridge;Ian Kerridge;Andrew Wilson

  • Evidence, Ethics, and Values: A Framework for Health Promotion

    Stacy M Carter;Lucie Rychetnik;Beverley Lloyd;Ian Kerridge

  • Death, dying and donation: organ transplantation and the diagnosis of death

    I Kerridge;P Saul;Michael Lowe;J McPhee

  • Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry.

    Paul A Komesaroff;Ian H Kerridge

  • A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia

    Simon Z He;Samantha Busfield;David S Ritchie;Mark S Hertzberg

  • Specific Unwillingness to Donate Eyes: The Impact of Disfigurement, Knowledge and Procurement on Corneal Donation

    M. Lawlor;M. Lawlor;I. Kerridge;R. Ankeny;T. A. Dobbins

  • Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk.

    Ian Kerridge;Lisa Lincz;Fiona Scorgie;Danica K. Hickey

  • Selection of medical students according to their moral orientation

    Miles Richard Bore;Donald Munro;Ian Kerridge;David Alan Powis

  • Tissue donation to biobanks: a review of sociological studies

    Wendy Lipworth;Wendy Lipworth;Rowena Forsyth;Ian Kerridge

  • Withdrawal and limitation of life-sustaining treatments in a paediatric intensive care unit and review of the literature

    Peter Moore;Ian Kerridge;Ian Kerridge;Jonathan Gillis;Stephen Jacobe

  • Ethics and Epistemology in Big Data Research.

    Wendy Lipworth;Paul H. Mason;Ian Kerridge;Ian Kerridge;John P. A. Ioannidis

  • Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma

    Lisa F. Lincz;Fiona E. Scorgie;Ian Kerridge;Rachelle Potts

  • The intention to hasten death: a survey of attitudes and practices of surgeons in Australia.

    Charles D Douglas;Ian H Kerridge;Katherine J Rainbird;John R McPhee

Frequent Co-Authors

Chris Ward
Chris Ward Newcastle University
Richard O. Day
Richard O. Day University of New South Wales
Stacy M Carter
Stacy M Carter University of Wollongong
Andrew Spencer
Andrew Spencer Monash University
Kenneth F. Bradstock
Kenneth F. Bradstock Westmead Hospital
David Isaacs
David Isaacs Children's Hospital at Westmead
David Henry
David Henry Bond University
David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Gwendolyn L. Gilbert
Gwendolyn L. Gilbert University of Sydney
Jennifer Fleming
Jennifer Fleming University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Social Sciences and Humanities in the USA opens up a range of online study options designed for flexibility and practicality. Many students are now seeking online master's programs for faster completion and the chance to balance work with study. These programs are especially popular in psychology, education, and social work.

If you’re looking for a faster route to a degree, accelerated online programs allow you to complete your studies in a shorter timeframe—potentially saving time and money. Such programs are ideal for motivated adults with prior college credits or relevant experience.

Students committed to making a difference in the community may consider social work. Fully accredited options like the most affordable msw programs online enable learners to advance their credentials without relocating or taking time off work.

For those drawn to behavior analysis or working with individuals with special needs, online bcba masters programs are accessible, affordable ways to qualify for national certification.

These online pathways offer flexibility, cost-savings, and preparation for diverse careers in helping professions, advocacy, research, and public service.

Best Scientists Citing Ian Kerridge

Trending Scientists